Prof.dr. R. Pieters

Current research

(the most recent research is at the top)
Supervisor The Social Psychology of Envy: An inquiry into the causes and consequences
Project leader Characterization of a novel BCRABL-like subtype with high relapse-risk in pediatric acute lymphoblastic leukemia
Project leader Molecular diagnosis of polymorphism of cytochrome P450 isoenzymes for optimalisation of chemotherapy in childhood cancer
Supervisor Chemotherapy Induced Intestinal Mucositis: from bench to bed
Supervisor Endocrine Effects of the Treatment for Acute Lymphoblastic Leukemia and Hodgkin's Lymphoma in Childhood
Supervisor Molecular-genetic Insights in Pediatric T-cell Acute Lymphoblastic Leukemia
Supervisor Identification of Prognose Genetic Factors in Pediatric T-cell Acute Lymphoblastic Leukemia
Supervisor Molecular determinants of asparaginase resistance in childhood leukemia
Project leader Polymorphism in the glucocorticoid receptor genes and abnormal receptors as determinants of resistance to glucocorticoid induced apoptosis
Project leader Molecular determinants of therapy response and outcome in childhood cancer
Project leader Training for Parents of Children with Newly Diagnosed Cancer: a Randomised Controlled Trial.
Project leader Prognostic relevance of molecular-genetic markers in pediatric T-cell acute lymphoblastic leukemia and identification of drugable targets
Project leader Can multi-color flowcytometric immunophenotyping replace PCR-based detection of minimal residual disease in childhood acute lymphoblastic leukemia?
Project leader Clinical application of genome-wide gene expression profiling in pediatric ALL; sub-classification, relapse prediction and causes of drug resistance
Project leader Involvement of HLXB9 and ETV6 in childhood acute leukemia and its relation to leukemogenesis and treatment outcome
Project leader Molecular alterations in the reduced folate carrier gene, multidrug resistance protein-mediated efflux and folate compartmentation: impact on cellular folate homeostasis and activity of antifolate drug in childhood leukemia
Project leader Definition of risk groups in infant acute lymphoblastic leukemia by prospective analysis of immunobiological characteristics, genetic abnormalities, drug resistance and minimal residual disease

Go to page top
Go back to contents
Go back to site navigation